These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. PSYCHODYNAMIC and therapeutic aspects of mescaline and lysergic acid diethylamide: round table. J Nerv Ment Dis; 1957; 125(3):423-4. PubMed ID: 13481746 [No Abstract] [Full Text] [Related]
5. [Central effects of lysergic acid diethylamide; studies on the localization of lysergic acid diethylamide effects]. NEUHOLD K; TAESCHLER M; CERLETTI A Helv Physiol Pharmacol Acta; 1957; 15(1):1-7. PubMed ID: 13428196 [No Abstract] [Full Text] [Related]
6. Some test findings associated with susceptibility to psychosis induced by lysergic acid diethylamide. PAUK ZD; SHAGASS C Compr Psychiatry; 1961 Aug; 2():188-95. PubMed ID: 14484460 [No Abstract] [Full Text] [Related]
7. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25). ISBELL H; MINER EJ; LOGAN CR Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871 [No Abstract] [Full Text] [Related]
8. Alleviation of the psychological effects of LSD in man by 5-hydroxytryptophan. BRENGELMANN JC; PARE CM; SANDLER M J Ment Sci; 1958 Oct; 104(437):1237-44. PubMed ID: 13621173 [No Abstract] [Full Text] [Related]
9. [Lysergic acid diethylamide (LSD-25) test and psychotropic therapy: electroencephalographic study]. Borenstein P; Cujo P; Olivenstein C Ann Med Psychol (Paris); 1965 Jul; 123(2):237-46. PubMed ID: 5852791 [No Abstract] [Full Text] [Related]
10. Potentiation of substance P by lysergic acid diethvlamide in vivo. KRIVOY WA Br J Pharmacol Chemother; 1961 Jun; 16(3):253-6. PubMed ID: 13754427 [TBL] [Abstract][Full Text] [Related]
11. Comparison of psychological effects of certain centrally acting drugs in man. KORNETSKY C; HUMPHRIES O; EVARTS EV AMA Arch Neurol Psychiatry; 1957 Mar; 77(3):318-24. PubMed ID: 13402265 [No Abstract] [Full Text] [Related]
12. Assay of lysergic acid diethylamide and its passage from blood into the perfused cerebral ventricles. DRASKOCI M Br J Pharmacol Chemother; 1960 Mar; 15(1):29-34. PubMed ID: 13818017 [TBL] [Abstract][Full Text] [Related]
13. Effects of D-lysergic acid diethylamide and 2-brom-lysergic acid diethylamide on dominance behavior of the rat. Uyeno ET Int J Neuropharmacol; 1966 Jul; 5(4):317-22. PubMed ID: 5965646 [No Abstract] [Full Text] [Related]
14. Subjective reports of lysergic acid experiences in a context of psychological test performance. COHEN S; FICHMAN L; GROVER EISNER B Am J Psychiatry; 1958 Jul; 115(1):30-5. PubMed ID: 13545391 [No Abstract] [Full Text] [Related]
15. Effects of lysergic acid diethylamide, and differences between normals and schizophrenics on the Stroop Color-Word Test. WAPNER S; KRUS DM J Neuropsychiatr; 1960; 2():76-81. PubMed ID: 13783079 [No Abstract] [Full Text] [Related]
16. [Preliminary notes on the use of LSD 25 in the production of experimental psychoses]. FRAGOSO MENDES J Med Contemp; 1956 Dec; 74(12):565-70. PubMed ID: 13386654 [No Abstract] [Full Text] [Related]
17. The effect of lysergic acid diethylamide, 5-hydroxytryptamine, and related compounds on the liver fluke, Fasciola hepatica. MANSOUR TE Br J Pharmacol Chemother; 1957 Dec; 12(4):406-9. PubMed ID: 13489165 [TBL] [Abstract][Full Text] [Related]
18. Lysergic acid diethylamide: role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine). Lin RC; Ngai SH; Costa E Science; 1969 Oct; 166(3902):237-9. PubMed ID: 5809595 [TBL] [Abstract][Full Text] [Related]
19. Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide. Green JP; Johnson CL; Weinstein H; Maayani S Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5697-701. PubMed ID: 23536 [TBL] [Abstract][Full Text] [Related]